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A B S T R A C T
Objective: While there is growing interest in improving patient activation in general medical health
services, there are too few randomized controlled trials in mental health settings which show how
improvement can be achieved. Using the Patient Activation Measure-13 (PAM-13), we aimed to assess the
effect of pre-treatment, peer co-led educational intervention on patient activation. Secondary outcomes
included measures of patient satisfaction, well-being, mental health symptoms, motivation, and
treatment participation.
Methods: Patients from two community mental health centres were randomized to a control group (CG,
n = 26) receiving treatment as usual, or an intervention group (IG, n = 26) consisting of a four-hour group
educational seminar (aiming to encourage patients to adopt an active role in their treatment) followed by
treatment as usual.
Results: Only the IG improved on PAM-13, at one- and four-month follow-ups. The intervention had
signiﬁcant effects on patient satisfaction and treatment participation, compared to CG.
Conclusion: Providing pre-treatment, peer co-led education improves patient activation in community
mental health care settings.
Practice implications: The use of peers as co-educators may contribute to a different mental health care
delivery, ensuring patient activation and participation in treatment. Further studies should examine
peers’ needs for supervision, challenges for the services, long-term and cost-beneﬁt effects.
Clinicaltrials.gov identiﬁer: NCT01601587.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Patient Education and Counseling
journa l homepage: www.e lsev ier .com/ locate /pate ducou1. Introduction
Patient activation is recognized as a key component in health
care reforms [1], emphasizing the importance of active patients
who know how to manage their own health. The concept of patient
activation speciﬁcally refers to the patient’s engagement and own* Corresponding author at: Tiller Community Mental Health Centre, Division of
Psychiatry, St. Olav’s University Hospital, Østre Rosten 55, N-7075, Tiller, Norway.
Fax: +47 72 82 39 01.
E-mail address: mariela.lara@ntnu.no (M.L. Lara-Cabrera).
1 Shared last author.
http://dx.doi.org/10.1016/j.pec.2015.11.028
0738-3991/ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/4.0/).understanding of her role in the health care process and having
knowledge, skills, behaviours, and conﬁdence to manage own
health and health care [2].
Strengthening patient activation is a growing area of research in
long-term and chronic conditions [1,3,4]. Evidence increasingly
demonstrates that patient activation, as measured by the Patient
Activation Measure-13 (PAM-13) developed by Hibbard et al. [5],
may contribute to improved self-management [6], higher engage-
ment in treatment [1,6], greater patient satisfaction [5,7], and
better health outcomes in patients with chronic conditions [1,4,8].
Research shows that educational interventions led or co-led by
peers improved outcomes in diabetes care [9], hypertension
control [10], general chronic conditions [7], as well asarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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[11]. These studies suggest that peer-led education may be a way to
improve activation. Three randomized controlled trials (RCTs) [12–
14] show similar results in mental health settings. These three US
studies investigated the effect of peer-led education by using two
different models: two [13,14] employed the Stanford Chronic
Disease Self-Management peer-led group programme, which
consisted of peer-led patient education and guided mastery of
skills through weekly action planning [9], and one [12] applied an
educational self-help support oriented group programme, the
Pathways to Recovery [15]. The latter reported a 7-point pre–post
improvement of in a small total follow-up sample of 28 patients.
Signiﬁcant pre–post differences in patient activation favouring the
peer-led intervention were reported by Godberg et al. [14], but this
did not remain at a two-month follow-up. Druss et al. [13] found
signiﬁcant improvement at a six-month follow-up, as well as
improvements in the proportion of persons using primary care
services, but no effects were found on adherence or quality of life.
There is a lack of evidence which demonstrates that such
interventions impact mental health outcomes.
The effect of peer co-led educational interventions on activation
is promising but limited by methodological weakness of the
studies (pilot design in two studies, reporting incomplete and
mixed outcome data), making it difﬁcult to draw conclusions with
respect to the ﬁndings’ robustness. Generalizability is also limited
due to the inclusion of only US patients with chronic, long-term,
and severe mental illness [12–14], predominantly African-Ameri-
can patients (two studies). Furthermore, evidence is lacking on the
effects of peer-led activation interventions on patient satisfaction
and well-being. Hence, there is a need to assess a variety of key
patient-centred outcomes.
Patient-centred interventions entail comprehensive efforts to
empower and recognize patients’ values, beliefs, and preferences
[16]. Such efforts require effective communication and patient
education, provision of information about treatment options, and
emotional support that encourage autonomy and participation in
own treatment [17]. Based upon this patient-centred framework and
the lack of research evidence for peer-led educational programmes,
we developed an educational intervention to prepare for out-patient
treatment early on. This was done in cooperation with peer
educators, user representatives, and health personnel. The inter-
vention’s main objective was to enhance patient’s ability, skills, and
conﬁdence to become actively involved in health and treatment, by
providing education and peer support.
Using a randomized controlled trial, the present study aimed to
evaluate the effect of a peer co-led intervention, added to
treatment as usual, on patient activation in out-patient mentalTable 1
Content of the peer co-led educational intervention.
Content 
Introduction 
What is mental health 
Orientation about treatment and how psychotherapy works 
Experiences with individual treatment: How to inﬂuence your own treatment? 
Break 
Expectations, goals and framework for the treatment 
Patients’ rights and practical information (e.g. attendance) 
Break 
Physical symptoms and mental health:
Physiotherapy as treatment
Encouraging patient participation and self-management groups (Stanford Course) 
Experiences with group treatment:
Pros and cons
Asking questions and small-group discussion 
Discussion and ﬁnal comments 
* Peer educators were user representatives from Mental Health Organizations and Vhealth care settings. Secondary aims were to assess the effects on
patient satisfaction, well-being, mental health symptomatology,
motivation, and treatment participation in mental health services.
2. Methods
2.1. Study design
The study was a parallel group randomized controlled trial
conducted in two community mental health centres (CMHCs) in
mid Norway with a catchment area of 170,000 inhabitants. The
trial was registered in clinicaltrials.gov (trial no. NCT01601587) and
was approved by the Regional Committee for Medical and Health
Research Ethics in Central Norway (no. 4,2009,77). Patients did not
receive payment for participation. The recruitment began in
November 2011 and was completed in May 2012.
Three assessment points were made equally for both groups:
baseline (i.e. before randomization during the waiting time), post-
test one month after baseline (follow-up 1), and four months after
baseline (follow-up 2). The persons administering the educational
interventions were not blinded to group allocation, but those
performing the main analyses were blinded.
2.1.1. The randomization arms: intervention and control group
The intervention consisted of a four-hour group pre-treatment
educational seminar (see Table 1) followed by regular treatment as
usual, i.e. a range of different treatments commonly given at
psychiatric outpatient clinics. Treatment started with an individual
therapy intake session, combining intake psychiatric evaluation
and identifying the patient’s service needs (psychotherapy,
medication, or a combination of various approaches). Mean
waiting time between the peer co-led educational intervention
and treatment initiation was 49 days (range = 12–90).
The pre-treatment educational programme was developed in
cooperation with health care professionals and user representa-
tives. It was based on the principles of patient involvement, peer-
support, and self-management, and drew from the literature on
pre-treatment preparation [18–22]. Between 9 and 15 patients
participated in each seminar. The objective was to encourage the
patients to participate actively in the treatment and to take an
active role in their own health. The educational methods employed
were of PowerPoint presentation (with corresponding printed
handouts), verbal information, and group discussion. During two
breaks the patients were encouraged to mingle and become
acquainted with self-help literature and leaﬂets from patient
organizations. All participants received a folder containing leaﬂets
on mental health disorders and treatment possibilities.Responsible Duration
Nurse 5 min
Psychiatrist 20 min
Psychologist 25 min
Peer-educator* 20 min
5–10 min
Psychologist 30 min
Social worker 30 min
5–10 min
Physiotherapist 10 min
Peer-educator* 10 min
Peer-educator* 10 min
Health personnel, Peer-educators & User representative 45 min
Nurse 10 min
ARRES.
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patient-centred approach [17] and consisted of eight main themes:
introduction to outpatient treatment, mental health and integra-
tion of care, treatment options and experiences with treatment,
patients’ rights, physical symptoms, patient participation, and self-
management. General education about mental health was given by
an experienced psychiatrist or a clinical psychologist, with a
holistic care approach. The main focus was on factors that can
affect mental health, such as stress, social, family and emotional
factors, as well as general information about treatment (pharma-
cological and psychological). Information about the therapy
process, expectations, prognosis and the patients’ and therapists’
roles was also given by a psychologist. Information about
treatment options and how to inﬂuence own treatment, along
with efforts to encourage patient participation, were provided by
peer-educators (focusing on self-experienced knowledge). Infor-
mation about individual care plans, treatment rights, coordination
of care, the importance of community and family resources,
economy and patients’ rights was given by an experienced social
worker. A physiotherapist lectured about bodily awareness in
mental health. Physical symptoms and management of bodily
discomforts commonly related to mental health problems were
discussed (i.e. muscle pain, muscle tenseness, breathing problems,
etc.), and a guided body awareness exercise was included in the
session.
A peer educator qualiﬁed as a Stanford course leader informed
the patients about self-management, by focusing on goal setting
and action planning. Information was also given about available
self-management groups.
The small-group session was mentored by a therapist (e.g.
nurse, psychologist) and peer educators. The objectives of the
small-group meeting were to enable the patients to discuss the
seminar contents, ask additional questions about the treatment
possibilities, provide emotional support, and reduce uncertainty.
Five predeﬁned questions were discussed: ‘What do you think
about the information you have been given today?’, ‘Do you have
any questions about how treatment works?’, ‘What do you think
about the treatment options for you?’, ‘What are the pros and cons
of individual and group treatment?’ and ‘Based on the information
presented today, from your point of view, what matters most for
you?’
Prior to the study, the peer educators received two training
sessions on pedagogic tools and workshops in order to facilitate
communication skills about shared decision-making and patient
participation. The health personnel did not receive any formal
training in advance.
The educational seminar was arranged in a room geographically
separated from the treatment facilities (therapist ofﬁces, waiting
rooms) and all other patients, and it was only accessible for the
participants in the intervention group. Only those randomized to
the intervention group received systematic information from the
peer educators and participated in the small-group session.
The control group (CG) received treatment as usual at the
CMHC, without any pre-treatment education. While they were
waiting for treatment (during the allocation appointment), the
control group received standard written information (a brochure).
The CMHCs provide different treatment such as assessment
service, drug therapy, time-limited or long term treatment, and
both individual and group psychotherapy.
2.2. Study participants and setting
The patients were recruited from six outpatient units in two
CMHCs. The units treat adults with a variety of mental disorders;
the most common were mood, anxiety, behavioural, emotional,
and personality disorders.2.3. Procedure
All patients with an estimated two- to four- month waiting time
for treatment were invited to participate in the study. The waiting
time, predetermined by the intake team before screening, was
based on the patients’ symptoms as described in the referral letter.
Once a week, the intake team at each unit screened for study
eligibility. They identiﬁed participants from referral documents
and based on 18 years of age and ability to understand Norwegian
as the inclusion criteria. Patients with a waiting time of less than
four weeks or with comprehension difﬁculties, i.e. severe dyslexia
or cognitive impairment, were not invited. Four weeks was chosen
because the intake teams needed at least four weeks to answer
referrals and screen for eligibility.
Patients were ﬁrst informed by mail, and then an employee at
the CMHC contacted them and informed them by telephone.
Interested patients were invited to a meeting (inclusion appoint-
ment). All participants received oral and written information
before the informed consent was collected. After completing the
baseline questionnaires, randomization was done via an Internet-
based computer programme provided by the Research Trial Service
Centre at the Norwegian University of Science and Technology. The
researchers were blind to block sizes. The blocks sizes were used to
ensure equal number of patients from both centres. Participants
were randomized 1:1 to receive either a pre-treatment educational
intervention followed by treatment as usual or treatment as usual,
without any pre-treatment education. The patients were informed
of their group allocation immediately after randomization.
To ensure ﬁdelity and adherence to the educational sessions,
the same educational programme and PowerPoint presentations
were used in the seminars. Using a checklist (tested in a separate
pilot study prior to the trial), an observer (ﬁrst author) rated the
presented topics, which ensured that the same information was
presented in all seminars. A peer educator was scheduled to
address missing seminar information by asking questions at the
session or by informing on this in small-group discussions. The
small-group leaders received a list with all predeﬁned questions, to
ensure that all questions were addressed in the small-group
discussions. Two check-up questions (reviewed in a post-seminar
meeting) conﬁrmed that the exercise ‘asking questions about
treatment options’ was properly addressed (see Appendix A).
2.4. Measures
The baseline assessment was completed at the centres.
Demographic data collected at baseline included gender, age,
employment status, education, living situation (living alone or
with family), and marital status. The primary and secondary
outcomes were collected at baseline and follow-up. The follow-up
questionnaires (one and four months after baseline) were mailed
to the participants. Information on diagnoses, ICD-10 diagnosis
(International Classiﬁcation of Diseases, version 10) [23], and
participation in mental health services (received treatment,
attendance, participation in collaborative meeting with primary
care) were obtained from the registry data four months after
baseline.
2.4.1. Primary outcome
The primary outcome was increased activation using the
Norwegian PAM-13 [5]. A validated Norwegian version with
acceptable psychometric properties for out-patients in mental
health settings was used [24]. The 13 items have four possible
response options ranging from (1) strongly disagree, to (4) strongly
agree, and an additional ‘not applicable’ option. The statements
cover beliefs (e.g. ‘When all is said and done, I am the person who
is responsible for managing my health condition’), conﬁdence
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have even when he does not ask’), knowledge (e.g. ‘I know the
different medical treatment options available for my health
condition’), and skills in taking action (e.g. ‘I know how to prevent
further problems with my health condition’). The transformed
scores range between 0 and 100, based on calibration tables
(higher PAM scores indicating higher patient activation) [25]. In
the current study, the Cronbach’s a coefﬁcient was 0.79.Flow  chart of the stu dy
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indicating greater satisfaction.
2.4.2.2. Patient satisfaction with mental health services. Patient
satisfaction was measured by the original CSQ-8 [26]. The scale
consists of eight items ranging from 1 (not satisﬁed) to 4 (very
satisﬁed). The 8 statements pertain to satisfaction with the quality
of the services, using items like ‘To what extent has our programme
met your needs?’, ‘Would you recommend our programme to a
friend?’, and ‘If you were to seek help again, would you come back
to our programme?’. The total score ranges from 8 to 32, with high
scores indicating greater satisfaction. In the current study, the
Cronbach’s a coefﬁcient was 0.79.
2.4.2.3. Well-being. Well-being was measured by the WHO-
5 Well-being Index, developed by the World Health
Organization [27]. The questionnaire has ﬁve items rated on a
six-point scale from 0 (all the time) to 5 (at no time), transformed
into 0–100 scales (high scores indicating a better well-being).
WHO-5 captures emotional well-being and contains ﬁve positively
worded items: ‘I have felt cheerful and in good spirits’, ‘I have felt
calm and relaxed’, ‘I have felt active and vigorous’, ‘I woke up
feeling fresh and rested’, and ‘My daily life has been ﬁlled with
things that interest me’. Among adults, WHO-5 has proved to be a
highly sensitive screener for depressive affect [28]. Cronbach’s a
coefﬁcient was 0.75 in this study.
2.4.2.4. Mental health symptomatology. Mental health
symptomatology was measured by the Behaviour and Symptom
Identiﬁcation Scale-32, BASIS-32 [29], which is composed of
32 items and measures the degree of difﬁculty patients have had
with various problems and areas of life functioning during the
preceding week. The items range from 0 (no difﬁculty) to 4
(extreme difﬁculty). These items have ﬁve subscales: relations
with self and others (seven items), daily living and role functioning
(seven items), depression and anxiety (six items), impulsive andTable 2
Socio-demographic and clinical data.
IG
(n = 24)
Age, mean (SD) 31.42 
Female, n 16 
Married, cohabitant, n 7 
ICD-10 Diagnosis, n 
Alcohol related, F 10 0 
Mood disorders, F 30–39 11 
Neurotic disorders, F 40–48 8 
Behavioural syndromes, F 50–59 1 
Personality disorders, F 60–69 1 
Behavioural and emotional disorders, F 90–98 2 
Others 1 
Education, n 
Primary 3 
Secondary 15 
Bachelor degree or higher 6 
Employment status, n 
Full-time 8 
Part-time or sick leave 11 
Student 2 
Retired or disability pension 2 
Other 1 
Living with someone, n 
Alone 7 
Family or others 17 
Waiting time, number of days, mean (SD) 110 
PAM-13 baseline, mean (SD) 48.25 addictive behaviour (six items), and psychosis (four items) [30].
Cronbach’s a coefﬁcient was 0.91 in this study.
2.4.2.5. Treatment motivation. Treatment motivation was
measured using a single self-developed question, ‘How
motivated are you towards your treatment?’ Motivation was
scored on a 6-point scale from 0 (not at all) to 5 (very much).
2.4.2.6. Treatment participation. Data on received treatment, the
percentage of non-attendance in scheduled sessions, and
participation in collaborative meetings with primary care were
obtained from the patient record registry four months after
baseline.
2.5. Data analysis
Power calculation was based assuming that PAM changes are
normally distributed. We achieved a power of 87%, with n = 25 in
the IG (mean 9.1, sd = 13.8) and CG (mean 0, sd = 9.7) using the two
tailed t-test, with an alpha of 0.05.
2.5.1. Analysis of baseline differences
Baseline analyses were performed with IBM SPSS for Windows,
version 22.0 [31]. To examine the effects of randomization, the
baseline characteristics of the two groups were compared via the
Chi-square test for categorical variables and the t-test for
independent samples for continuous variables.
2.5.2. Analysis of primary and secondary outcomes
Outcome analyses were conducted on an intention-to-treat
principle with mixed linear models using IBM SPSS, version 22
[31], and R [32]. Missing data analysis was handled at the
individual level via mixed linear models. Both primary and
secondary outcome statistics were performed by a statistician
(ØS) who was blinded to group allocation. To account for within-
subject correlations, patients IDs were speciﬁed as a random effect.CG
(n = 26)
p-value
10.4 31.88 11.6 0.88
66.7% 14 53.8% 0.35
29.2% 10 38.5% 0.56
0.94
1 3.8%
45.8% 11 42.3%
33.3% 7 26.9%
4.2% 0 0.0
4.2% 1 3.8%
8.3% 4 15.4%
4.2% 2 7.7%
0.64
12.5% 2 7.7%
62.5% 14 53.8%
25.0% 10 38.5%
0.15
33.3% 9 34.6%
45.8% 7 26.9%
8.3% 6 23.1%
8.3% 0 0.0
4.2% 4 15.4%
0.96
29.2% 7 26.9%
70.8% 19 73.1%
25.22 107 48.7 0.40
10.2 51.51 12.3 0.31
Table 3
Between-group comparison for primary and secondary outcomes at 1- and 4-month follow-up, with model-based intention to treat and per protocol analyses.
Outcome Model-based
difference between groups
at 1 month
Model-based difference between groups
at 4 months
Per protocol analyses
from baseline to 1-month follow-up
Per protocol analyses
from baseline to
4-month follow-up
Mean
baseline
Mean
diff.
95% CI p Mean diff. 95% CI p Mean
baseline
Mean
diff
95% CI p Mean
diff
95% CI p
PAM-13a 49.95 6.98 1.71, 12.26 0.01 6.09 0.35, 11.84 0.04 50.19 8.25 2.60, 13.89 0.004 6.55 0.60, 12.50 0.03
CSQ-8a 18.60 5.87 3.32, 8.41 <0.001 1.19 -1.63, 4.00 0.41 18.86 6.87 4.17, 9.57 <0.001 1.38 -1.49, 4.25 0.35
WHO-5a 28.16 4.94 -4.10, 13.98 0.28 4.67 -5.08, 14.42 0.35 28.78 7.37 -1.60, 16.35 0.11 2.23 -7.24, 11.71 0.64
Motivationa 3.84 0.29 -0.26, 0.84 0.30 0.08 -0.50, 0.67 0.79 3.83 0.30 -0.30, 0.89 0.33 0.03 -0.59, 0.65 0.93
BASIS-32b 1.70 -0.16 -0.39, 0.08 0.19 0.00 -0.26, 0.25 0.98 1.66 -0.22 -0.47, 0.02 0.07 -0.02 -0.27, 0.24 0.90
PAM-13: Patient Activation Measure-13; CSQ-8: Client Satisfaction Questionnaire-8; WHO-5: Well-being Index-5 items; BASIS-32: Behaviour and Symptom Identiﬁcation
Scale-32.
a Increase in score indicates improvement.
b Decrease in score indicates improvement and fewer mental health problems.
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ﬁxed effect at the following ﬁve levels, ‘baseline’, ‘intervention-
one-month’, ‘intervention-four-months’, ‘control-one-month’, and
‘control-four-months’ (intervention and control group patients
were assumed not to be systematically different at baseline
because of randomization). Table and ﬁgure contents were
predeﬁned, before statistical analysis. Chi-square, non-parametric,
and Student’s t-tests were performed to test for differences on
treatment participation for all patients at four months.
Per protocol analyses were conducted by including only those
participants receiving the educational intervention (n = 20).
3. Results
Of the 159 patients who were contacted and invited to
participate, 69 (43%) responded positively to the invitation
(Fig.1). Seventeen were not randomized, because they participated
in other studies. Fifty-two were randomized to intervention group
(IG, n = 26) or control group (CG, n = 26). Two participants who
were randomized to IG withdrew their consent to participate andTable 4
Intention to treat within-group comparison for primary and secondary outcomes for the
follow-up, with observed and model-based values.
Outcomes,
group
Observed values Model-based values
Within-group differen
Baseline
mean
Mean change, 1 month Mean change,
4 months
Model
baseline
mean
Mean Mea
PAM-13a
IG 48.25 9.83 12.31 49.95 58.96 9.01
CG 51.52 1.4 4.6 51.98 2.03
CSQ-8a
IG 17.87 5.66 4.91 18.60 23.65 5.05
CG 19.36 1.17 2.50 17.79 0.8
WHO-5a
IG 28.67 6.00 12.89 28.16 34.69 6.53
CG 27.69 1.67 9.71 29.75 1.59
Motivationa
IG
CG
3.79 0.18 0.11 3.84 3.98 0.14
3.88 0.17 0.24 3.69 0.1
BASIS-32b
IG 1.77 0.19 0.16 1.70 1.50 0.1
CG 1.63 0.00 0.17 1.66 0.0
PAM-13: Patient Activation Measure-13; CSQ-8: Client Satisfaction Questionnaire-8; WH
Scale-32.
a Increase in score indicates improvement.
b Decrease in score indicates improvement and fewer mental health problems.were not included in the analyses. Illness, work, or change of
residence prevented four IG patients from participating in the
educational session.
3.1. Baseline and clinical characteristics
There were no group differences on any baseline demographic
or clinical characteristics, or the waiting time. About 50% of the
participants had mood disorders and 30% had anxiety disorders.
None had psychotic disorders (see Table 2 for details).
3.2. Primary outcome: PAM-13
Intention to treat analysis using linear mixed model showed
that the IG had a signiﬁcantly greater improvement than the CG on
PAM-13 from baseline to one-month follow-up (p = 0.01) and from
baseline to four-month follow-up (p = 0.04) Within-group analyses
showed that the IG signiﬁcantly improved after one month
(p < 0.001) and four months (p < 0.001). CG signiﬁcantly improved
only after four months (p = 0.005) (Table 3). Intervention Group (IG) and the Control Croup (CG) at one-month and four-month
ces (1 month)
Model-based values
Within-group differences (4 months)
n change 95% CI p-value Mean Mean change 95% CI p-value
 5.04, 12.98 <0.001 61.76 11.81 7.41, 16.21 <0.001
 1.79, 5.84 0.30 55.67 5.72 1.70, 9.74 0.005
 3.05, 7.05 <0.001 22.83 4.23 2.05, 6.40 <0.001
2 2.72, 1.09 0.40 21.64 3.04 0.96, 5.11 0.004
 0.43, 13.49 0.07 42.07 13.91 6.37, 21.45 <0.001
 5.11, 8.29 0.64 37.40 9.24 2.18, 16.30 0.01
 0.29, 0.57 0.52 3.74 0.10 0.56, 0.37 0.68
5 0.57, 0.27 0.49 3.66 0.18 0.61, 0.26 0.42
9 0.37, 0.01 0.03 1.48 0.22 0.41,0.03 0.03
3 0.20, 0.13 0.69 1.48 0.22 0.39,0.04 0.02
O-5: Well-being Index- 5 items; BASIS-32: Behaviour and Symptom Identiﬁcation
Table 5
Treatment participation and the use of mental health services, comparing the intervention group (IG) and the control group (CG) four months after baseline, using intention to
treat and per protocol analyses.
Outcomes Intention to treat analyses Per protocol analyses
IG
(n = 24)
CG
(n = 26)
p-value IG
(n = 20)
CG
(n = 26)
p-value
Treatments status
Waiting for treatment, n,% 1 4.2% 2 7.7% 1.0a 0 0% 2 7.7% 0.50a
Intake session only, n,% 1 4.2% 2 7.7% 1.0a 1 5% 2 7.7% 1.0a
Individual treatment, n,% 18 75% 14 53.8% 0.149 15 75% 14 53.8% 0.22
Drug treatment in combination with individual therapy, n,% 1 4.2% 8 30.8% 0.024a 1 5% 8 30.8% 0.06a
Group treatmentc, n,% 3 12.5 0 0% 0.103a 3 15% 0 0% 0.08a
Psychomotor physiotherapy in combination with individual therapy, n,% 4 16.7% 0 0% 0.046a 4 20% 0 0% 0.003a
Planned and attended sessions
Number of planned sessions, mean, SD 5.92 4.44 4.77 2.94 0.695b 6.30 4.49 4.77 2.94 0.49 b
Number of attended sessions (including intake sessions), mean, SD 5.58 4.42 3.77 3.08 0.181b 6.00 4.57 3.77 3.08 0.11 b
Non-attendance,%, SD 8.0% 17.6% 27.6% 35.9% 0.035b 8.6% 18.9% 27.6% 35.9% 0.049 b
Participation in collaborative meetings, n,% 6 25% 1 3.8% 0.045a 5 25% 1 3.8% 0.072 a
a Fisher’s Exact test.
b Mann-Whitney U-test.
c The participants received ﬁrst individual treatment followed by group treatment.
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Satisfaction with the educational intervention was high (mean
3.28): 38.9% were ‘Very satisﬁed’, 55.6% were ‘Mostly satisﬁed’,
5.5% were ‘Indifferent or mildly dissatisﬁed’, and 0% were ‘Quite
dissatisﬁed’.
The between-group intention to treat analyses revealed that the
IG had a signiﬁcantly greater improvement than the CG in patient
satisfaction at one-month follow-up (CSQ-8, p < 0.001). No
statistical differences were found between groups regarding
well-being, motivation, or mental health at one- or four-month
follow-up (Table 3).
Within-group analyses showed that the IG experienced
signiﬁcantly greater satisfaction (p < 0.001) and improved mental
health at one month (BASIS-32, p = 0.03). At four months both
groups improved signiﬁcantly in satisfaction (CSQ-8, IGs p < 0.001;
CGs p = 0.004), well-being (WHO-5, IGs p < 0.001; CGs p = 0.01),
and mental health (BASIS-32, IGs p = 0.03; CGs p = 0. 02) (Table 4).
There were signiﬁcant between-group differences with respect
to treatment participation at four months (Table 5). CG patients
received signiﬁcantly more drug treatment and had a signiﬁcantly
higher percentage of non-attendance to scheduled sessions. IG
patients had signiﬁcantly more collaborative meetings with
primary care services and signiﬁcantly more psychomotor
physiotherapy in combination with individual treatment.
3.4. Per protocol analyses
Per protocol analyses were conducted by including only those
participants who received the intervention (n = 20). Compared
with the intention to treat analysis, the observed values tended to
change in favour of the intervention group (Tables 3 and 5).
4. Discussion and conclusion
The present study found a signiﬁcant effect from a peer co-led
educational intervention added to mental health outpatient
treatment on patient activation, at one month and four months,
as compared to treatment as usual. The patients in the
intervention group reported improvements on patient satisfac-
tion and treatment participation, compared to CG. The results are
in line with other studies showing that peer-led educational
interventions improve patient activation [12–14]. Moreover, our
ﬁndings add to the sparse knowledge about the effects ofinterventions aimed at improving patient activation in mental
health services [1].
4.1. Discussion
This study demonstrated that patients in the intervention group
were satisﬁed with the educational intervention (using a single
item) and that it caused more satisfaction with the health services
(one month after baseline, using the CSQ-8). Nevertheless, this
should be considered with caution due to the use of a single
question in assessing satisfaction with the educational interven-
tion, and because there was an attenuation from one- to four-
month follow-up.
This study found signiﬁcant mean group differences in patient
activation of six (four months) to seven points (one month). Studies
have demonstrated that a meaningful PAM improvement is above
four points [33,34]. Interestingly, compared with other peer-led
interventions, this is the ﬁrst study showing that treatment as
usual can improve activation. The within-group improvement at
four months may be explained by differences found in received
treatment (more controls received drug treatment). However, the
small sample size prevents us examining the differential effects of
other explanatory factors. Nevertheless, the fact that between-
group differences showed that the peer co-led educational
intervention resulted in earlier activation and improved atten-
dance lends support for advocating for peer co-led education. Such
interventions may be useful for mental health services struggling
to ﬁnd ways to improve engagement, and therefore these ﬁndings
need to be replicated.
There were no improvements in mental health symptomatolo-
gy, motivation, or well-being. Yet, per protocol analyses revealed
that the between- and within-group differences favoured the IG
with respect to mental health symptomatology and well-being
(after one month). Consequently, these ﬁnding merit larger studies
to draw deﬁnitive conclusions. Larger studies will likewise be
helpful for exploring the differential effects of peer-led pro-
grammes, i.e. if patients with lower PAM scores beneﬁt more from
such interventions, and how such effects are associated with
mental health improvement or well-being.
4.1.1. Limitations and strengths
The results should be interpreted with caution due to the small
number of participants and relatively short follow-up period in a
sample with predominantly depressive and anxiety disorders.
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with caution due to the use of a single question. Important
strengths of this study were randomization, multi-centre admin-
istration, few exclusion criteria, a good follow-up rate, the use of
both patient self-reported and register data, and the blinded
statistical analyses.
4.2. Conclusion
Our study shows that providing pre-treatment, peer co-led
education improves patient activation in community mental
health care settings, suggesting that peer-led education can be a
useful strategy for early engagement of outpatients in their own
health. Yet this study also suggests the need for more research.
4.3. Practice implications
The use of peers as educators may ensure patient activation and
participation. It may contribute to a different mental health care
delivery, where peer educators, in cooperation with health
personnel, enable patients to be actively involved in their own
treatment at an early stage. Many mental services have limited
capacity. Hence, there is a need for new alternatives to activate
patients, such as using peer co-led educational models, based on a
patient-centred care approach. Peer educators may need training,
and further studies should examine their need for supervision in
order to facilitate implementation or sustainability. Furthermore,
studies are needed to understand the possible challenges for the
services when implementing peer co-led education in regular
clinical settings.
Further research should seek to evaluate patient satisfaction
with peer-led educational interventions as well as investigate
which patients beneﬁt most from such interventions. It is
important to acquire knowledge about the differential effects of
interventions, for example effects associated with low or high
initial activation. We also need knowledge about the effect of
interventions on treatment attendance and received treatment, its
long-term effects, and the cost-beneﬁt consequences.
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Appendix A.
Quality checklist to ensure correct information dose (mean across
seminars), the use of presentation materials, and goal achievement.
Key ingredients Mean
total
Handouts Goals
achieved
Structure (0–15): 15 Yes Yes(Continued)
Key ingredients Mean
total
Handouts Goals
achieved
Operating: At least two peers are active during
the day (0–5)
Responsive: The peers are responsive to the
needs of the participants (asking questions)
(0–5)
Linkage: The peers establish links to CMHC
and primary care (0–5)
Environment (0–20): 20 Yes Yes
Accessible: The seminar room is accessible only
for participants (0–5)
Setting: A comfortable setting (0–5)
Pleasant: Welcoming (with coffee and tea)
(0–5)
Breaks: The staff and peers are without
distinctions; fresh fruit with cakes or
sandwiches (0–5)
Belief systems (0–40): 37.8 Yes Yes
Peer principle: The programme is based on
shared experiences and values of respect (0–
5)
Empowerment: Personal empowerment is
encouraged and supported by the peers and
health personnel (0–5)
Decision-making process: Participants are
encouraged to take an active role in
treatment (0–5)
Participation: Information is given about the
importance of participation and treatment
choices (0–5)
Options and choices (option of changing
therapist) (0–5)
Recovery: Acknowledges patients owns
values and strength, enhances participants’
well-being (0–5)
Respect: The value of respect is conveyed (0–
5)
Spiritual needs: The information about this is
given by the peers (0–5)
Peer support (0–15): 15 Yes Yes
Information about peer support groups is given
and the written information is accessible for
all (0–5)
Telling Stories: Two of the peers shared their
experiences as a mental health consumer (0–
5)
Consciousness-raising: One peer informs
about user participation and how to
contribute as user representative (0–5)
Education (0–50): 49 Yes Yes
Mental health and holistic approach (0–5)
Treatment options (0–5)
How to inﬂuence in own treatment (0–5)
Expectations, goals, and framework for
treatment (0–5)
Experiences with treatment (0–5)
Individual treatment and treatment plan (0–
5)
Patients’ rights (0–5)
Physical symptoms and one exercise (body
awareness exercise) (0–5)
Self-management model and strategies
related to health promotion (0–5)
Peers: Working with asking questions, goal
setting (0–5)
Advocacy-education and skills training (0–20): 19.3 No Yes
Peers support about how to ﬁnd one’s own
voice (0–5)
Psychologist explains the importance of
becoming active partners in own treatment
(0–5)
Small group discussion: All participants
participated in the discussion (0–5)
Small group discussion: Were the ﬁve
questions asked? (0–5)
(Not
necessary)
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